Quantbot Technologies’s Bioventus BVS Stock Holding History

Quantbot Technologies’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$281K	Buy	+20,652	New	+$272K	0.01%	1220
2025 Q3	–	Sell	-20,027	Closed	-$133K	–	1757
2025 Q2	$133K	Buy	20,027 +280	+1%	+$1.99K	﹤0.01%	1331
2025 Q1	$181K	Buy	19,747 +9,931	+101%	+$99.2K	0.01%	1149
2024 Q4	$103K	Buy	+9,816	New	+$116K	﹤0.01%	1191
2024 Q3	–	Sell	-20,588	Closed	-$118K	–	1470
2024 Q2	$118K	Buy	+20,588	New	+$113K	0.01%	1089
2023 Q4	–	Sell	-5,600	Closed	-$18.5K	–	1597
2023 Q3	$18.5K	Buy	5,600 +900	+19%	+$3.16K	﹤0.01%	1360
2023 Q2	$13.6K	Buy	+4,700	New	+$9.02K	﹤0.01%	1445

Other funds holding BVS

Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return

Quantbot Technologies's BVS Position: Q3 2026 in Review

Quantbot Technologies opened a new position in Bioventus (BVS) in Q3 2026: 20,652 shares worth $281K. The stake represents 0.01% of the portfolio and ranks #1220 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in BVS as recently as Q2 2025.

Quantbot Technologies first reported a position in BVS in Q2 2023 and has held it in 7 quarters since. 127 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

Quantbot Technologies held 20,652 shares of Bioventus worth $281K as of Q3 2026.
Bioventus was a new Quantbot Technologies position in Q3 2026.
Bioventus made up 0.01% of Quantbot Technologies's portfolio in Q3 2026, its #1220 holding.
Quantbot Technologies first reported a position in Bioventus in Q2 2023 and has held it in 7 quarters since.
127 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.